ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1SCImago #32,178Top JournalHybrid

Theranostics

Abbreviation (ISO):THERANOSTICS
•
Identifier (ISSN):1838-7640(Print)
•
Publisher:Ivyspring International Publisher
Clarivate IF (2026)
14.9↑ +1.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Theranostics

WoS Q1
51015208.5420188.0620198.58202011.6202111.6202212.4202312.4202413.3202514.92026
Annual Impact Factor Metric
Current (2026):14.9
Scopus SJR & Rank
N/A
#32,178

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
199

199 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
605articles/year
99.92% Gold OA•80.51% Original Research

Aims & Scope

Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications

Topics Covered (Recognized by AI)
Biology96.8%Medicine93.5%Genetics88.8%Chemistry87.6%Internal medicine78.4%Biochemistry76.2%Cancer research50.8%Gene39.6%Physics39.1%Cell biology38%Cancer37.6%Pathology35.8%Immunology33.8%Organic chemistry31.1%Materials science29.3%Biotechnology24.9%Engineering23.7%In vivo23.4%Nanotechnology23.1%Psychology23.1%Endocrinology22.5%Quantum mechanics21.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q1
Rank6/191
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q1
Rank4/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF14.9
Articles / Year289
Total Citations392
2025
IF13.3
Articles / Year571
Total Citations5,766
2024
IF12.4
Articles / Year458
Total Citations12,044
2023
IF12.4
Articles / Year332
Total Citations14,388
2022
IF11.6
Articles / Year448
Total Citations25,629

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #32,178SCImago Profile
Scopus Coverage:2011-2025
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)
—

Weighted prestige citation metric per document indexed in the Scopus database.

Normalized Data
Citations / Doc (2 years)
14.16

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,993 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations18,471
3-Year Documents1,199
Citable Documents1,199

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)—
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)—
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Theranostics (abbr: THERANOSTICS, ISSN: 1838-7640) is a peer-reviewed international scholarly journal in the field of MEDICINE, published by Ivyspring International Publisher in Australia since 2011. The periodical holds a Journal Impact Factor (JIF) of 14.9, ranking in quartile Q1 of Web of Science (SCIE), an H-index of 199.

The journal enforces rigorous peer evaluation with an annual output of approximately 605 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,993 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Ivyspring International Publisher
Publication Language
English
Frequency
Periodic
Founding Year
2011
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
PO BOX 4546, LAKE HAVEN, AUSTRALIA, NSW, 2263

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 02f48f15-208b-4e61-8d7f-190688a900ec
Database Updated: 2026-10-01